论文部分内容阅读
慢性肾病和终末期肾病发病率在世界范围内呈现上升趋势,并且合并冠心病和心肌梗死时易导致病死率增加。终末期肾病患者冠状动脉病变弥漫且多伴有严重钙化,行介入治疗预后较差,出血及血栓事件多见。因此冠状动脉介入治疗时应采用复杂病变简单处理的方法,充分评估出血和血栓风险,并采用肾脏保护措施以防止对比剂肾病的发生。
The incidence of chronic kidney disease and end-stage renal disease in the world showed an upward trend, and combined coronary heart disease and myocardial infarction easily lead to increased mortality. End-stage renal disease patients with coronary artery disease diffuse and often accompanied by severe calcification, interventional treatment of poor prognosis, bleeding and thrombotic events more common. Therefore, coronary intervention should be simple treatment of complex lesions should be used to fully assess the risk of bleeding and thrombosis, and the use of kidney protection measures to prevent the occurrence of contrast-induced nephropathy.